Literature DB >> 31143830

Evolutionary aspects of Parvovirus B-19V associated diseases and their pathogenesis patterns with an emphasis on vaccine development.

Piyanki Das1, Koustav Chatterjee1, Nabanita Roy Chattopadhyay1, Tathagata Choudhuri1.   

Abstract

Parvovirus B-19, a single human pathogenic member of the Parvoviridae family with it's small ssDNA and non-enveloped structure, is known to cause diseases in erythroid progenitor cells. But a wide range of clinical association of this virus with cells of non-erythroid origins has recently been discovered and many of those are being investigated for such association. Higher substitution rates in due course of evolution has been suggested for this cellular tropism and persistence. In this report, we have summarized the different disease manifestations of B-19 virus and have tried to find out a pattern of pathogenesis. Finally, we have focused on the vaccination strategies available against B-19 virus to correlate these with the mechanisms involved in various diseases caused by this virus.

Entities:  

Keywords:  Disease manifestations; Parvovirus B-19 (B-19V); Productive and non-productive mechanisms; Vaccine development

Year:  2019        PMID: 31143830      PMCID: PMC6517593          DOI: 10.1007/s13337-019-00525-6

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  56 in total

1.  Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans.

Authors:  E Zuffi; E Manaresi; G Gallinella; G A Gentilomi; S Venturoli; M Zerbini; M Musiani
Journal:  Viral Immunol       Date:  2001       Impact factor: 2.257

Review 2.  Antibodies, viruses and vaccines.

Authors:  Dennis R Burton
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

Review 3.  Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease.

Authors:  M Osaki; K Matsubara; T Iwasaki; T Kurata; H Nigami; H Harigaya; K Baba
Journal:  Ann Hematol       Date:  1999-02       Impact factor: 3.673

4.  Persistent erythrovirus B19 urinary tract infection in an HIV-positive patient.

Authors:  L S Christensen; T V Madsen; T Barfod
Journal:  Clin Microbiol Infect       Date:  2001-09       Impact factor: 8.067

5.  Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.

Authors:  T Lowin; U Raab; J Schroeder; R Franssila; S Modrow
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2005 Sep-Oct

6.  Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1.

Authors:  W Ripley Ballou; Jennifer L Reed; William Noble; Neal S Young; Scott Koenig
Journal:  J Infect Dis       Date:  2003-02-07       Impact factor: 5.226

7.  Parvovirus B19 infection associated with severe aplastic anemia in an immunocompetent patient.

Authors:  Sevgi Yetgin; Mualla Cetin; Emel Ozyürek; Deniz Aslan; Duygu Uçkan
Journal:  Pediatr Hematol Oncol       Date:  2004 Apr-May       Impact factor: 1.969

Review 8.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 9.  Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19.

Authors:  Amanda Corcoran; Sean Doyle
Journal:  J Med Microbiol       Date:  2004-06       Impact factor: 2.472

10.  Aplastic anaemia associated with parvovirus B19 infection.

Authors:  X H Qian; G C Zhang; X Y Jiao; Y J Zheng; Y H Cao; D L Xu; C S Chen
Journal:  Arch Dis Child       Date:  2002-11       Impact factor: 3.791

View more
  2 in total

Review 1.  Is the ZIKV Congenital Syndrome and Microcephaly Due to Syndemism with Latent Virus Coinfection?

Authors:  Solène Grayo
Journal:  Viruses       Date:  2021-04-13       Impact factor: 5.048

2.  Multisystem Involvement Induced by Human Parvovirus B19 Infection in a Non-immunosuppressed Adult: A Case Report.

Authors:  Qihang Zou; Peisong Chen; Jiaxin Chen; Dingbang Chen; Han Xia; Ling Chen; Huiyu Feng; Li Feng
Journal:  Front Med (Lausanne)       Date:  2022-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.